Recently, the 24th CPHI & PMEC China 2026 successfully concluded at the Shanghai New International Expo Centre. The three-day industry grand event gathered numerous benchmark enterprises across the global pharmaceutical industry chain. Purist made a strong appearance with its core UV photochemical synthesis technology. The professional technical team led by Liu Yuelin was stationed at the booth throughout the exhibition, conducting in-depth communication with R&D and production directors from dozens of pharmaceutical enterprises. Supported by solid technical strength and customized services, Purist won wide recognition from the industry, marking a successful conclusion of the exhibition participation and exchanges.
Deeply Focusing on Photochemical Synthesis to Solve Core Process Pain Points of Pharmaceutical Enterprises
During the exhibition, Purist’s booth attracted a steady stream of visitors. Many R&D engineers and technical directors from API, pharmaceutical intermediate and fine pharmaceutical enterprises paid special visits. Centering on the core track of photochemical synthesis of pharmaceutical intermediates, Liu Yuelin’s technical team provided one-on-one technical diagnosis for visiting pharmaceutical enterprises, targeting prevalent industry pain points including low reaction conversion rate, excessive by-products, high energy consumption and unstable mass production performance.
Customized Exclusive Solutions: Tailor-made implementable photochemical synthesis solutions based on customers’ existing production lines, with accurate calculation for process optimization and upgrading.
Interpretation of Cutting-edge Trends: Shared the latest developments in pharmaceutical photochemical synthesis, and deeply analyzed the implementation paths of green, continuous and low-pollution new pharmaceutical processes.
Intuitive Value Demonstration: Fully elaborated the core technical advantages of Purist’s UV photoreaction system, and intuitively demonstrated its comprehensive value in cost reduction, environmental protection and yield improvement by comparing with traditional thermal synthesis processes.
The on-site communication atmosphere was extremely active, and many customers showed strong intention of cooperation in replacing traditional synthesis routes with UV photochemical technology. For customers who failed to conduct in-depth communication on site, the team has formulated follow-up follow-up plans, including on-site enterprise surveys and special online video technical seminars, to ensure all communication demands are fully fulfilled.
Building Trust and Long-term Cooperation Opportunities Through Professional Technology
During the three-day on-site reception, Purist won high praise from major pharmaceutical enterprises relying on its mature complete sets of pharmaceutical photochemical equipment, rich mass production implementation cases of intermediates and one-stop supporting process services. Many new and existing customers reached preliminary cooperation intentions on site and confirmed to launch technical docking immediately after the exhibition. Peer enterprises also stopped by for in-depth exchanges to explore the upgrading direction of green pharmaceutical production.
Here, the entire team of Purist extends our sincerest gratitude to all industry colleagues who visited our booth and trusted and supported us! CPHI is not only a feast for products and technologies, but also a vital bridge for connecting demands and exploring transformation paths with industry partners.
Exhibition Concludes, Technical Services Never Stop
The end of the exhibition marks a brand-new starting point for in-depth cooperation. Purist’s full-range UV photochemical service system remains fully open. Whether you are an enterprise engaged in pharmaceutical intermediate R&D, a large-scale API production factory, or a pharmaceutical manufacturer seeking process upgrading and green transformation, you can get in touch with Liu Yuelin’s technical team at any time.
On-site Investigation: Book engineers for on-site evaluation of existing reaction kettles and synthesis production lines.
Special Seminars: Launch online video conferences for one-on-one explanation of customized photochemical synthesis solutions.
Free Calculation & Evaluation: Provide free process assessment and production line optimization calculation services.
Pilot Test Support: Support sample pilot tests to facilitate process verification and rapid project implementation.
Against the general trend of green transformation in pharmaceutical manufacturing, Purist will continue to deepen the R&D of UV photochemical reaction technology and iteratively upgrade complete photoreaction equipment adapted to pharmaceutical intermediate synthesis. With cutting-edge technologies and full-process supporting services, we will help domestic pharmaceutical enterprises reduce costs, improve efficiency and achieve compliant production. We look forward to in-depth cooperation with all industry partners met at this exhibition, jointly exploring the new track of green pharmaceutical synthesis and embracing a new future of high-quality industrial development!